Company Info
| Industry | Medical Specialties |
|---|---|
| Sector | Health Technology |
| Employees | 50 |
| CEO | Mr. Ran Poliakine |
| Address | Communications Center Neve Ilan Media Park, Neve Ilan, JM 9085000 |
|---|---|
| Phone | 972.2.995.0506 |
| Website | www.nanox.vision |
Nano-X Imaging Ltd. engages in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository; radiologist matching; online and offline diagnostics review and annotation; connectivity to diagnostic assistive artificial intelligence systems; billing; and reporting. The company was founded by Ran Poliakine and Hitoshi Masuya on December 20, 2018 and is headquartered in Neve Ilan, Israel.
Statement Summary
as of 4:00 ET PM 01/19/2022| Total Assets (MRQ) | 218.1 M |
|---|---|
| Total Liabilities (MRQ) | 9.9 M |
| Shareholders’ Equity (MRQ) | 208.2 M |
| Total Revenue (Annual) | n/a |
| Net Income (Annual) | -13.5 M |
Earnings And Estimates
as of 4:00 ET PM 01/19/2022
| Current Qtr EPS Estimate | -0.33 |
|---|---|
| Current FY EPS Estimate | -1.34 |
| Long Term EPS Growth Estimate | 3.00 |
| Next Expected Earnings Date | 3/1/2022 |
NNOX vs S&P 500
as of 01/19/2022| Relative To S&P 500 |
NNOX | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:00 ET PM 01/19/2022| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/2021 | -0.28 | -0.28 | 0.00% |
| 06/2021 | -0.26 | -0.28 | +9.80% |
| 03/2021 | -0.23 | -0.15 | -33.82% |
| 12/2020 | -0.21 | -0.18 | -12.20% |
| 09/2020 | -0.22 | -0.29 | +29.85% |
Financial Strength
as of 4:00 ET PM 01/19/2022| Pre-Tax Margin | 0.00 |
|---|---|
| Net Margin | 0.00 |
| Operating Margin | 0.00 |
| Return On Equity | -26.27 |
| Return On Assets | -25.33 |
| Inventory Turnover (TTM) | 0.00 |
| Sales Growth (MRQ) | n/a |
Ratios
as of 4:00 PM ET 01/19/2022| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 2.56 |
| Price/Cash Flow (TTM) | 0.00 |
| Book Value (MRQ) | 4.35 |
| Quick Ratio (MRQ) | 17.96 |
| Current Ratio (MRQ) | 17.96 |
| Total Debt/Equity (MRQ) | 0.02 |
Short Interest
as of 4:00 PM ET 01/20/2022| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 01/19/2022| Current Qtr (12/2021) |
Next Qtr (03/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.33 | $-0.25 |
| # of Estimates | 3 | 3 |
| High Estimate | $-0.25 | $-0.16 |
| Low Estimate | $-0.42 | $-0.30 |
| Year Ago EPS | $-0.41 | $-0.27 |
| Year Over Year Growth Estimate | -19.83% | -7.92% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $-1.34 | $-1.31 |
| # of Estimates | 3 | 3 |
| High Estimate | $-1.09 | $-1.18 |
| Low Estimate | $-1.72 | $-1.39 |
| Year Ago EPS | $-0.53 | $-1.34 |
| Year Over Year Growth Estimate | 152.20% | -2.24% |
| Current Qtr (12/2021) |
Next Qtr (03/2022) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.33 | $-0.25 | $-1.34 | $-1.31 |
| # of Estimates | 3 | 3 | 3 | 3 |
| High Estimate | $-0.25 | $-0.16 | $-1.09 | $-1.18 |
| Low Estimate | $-0.42 | $-0.30 | $-1.72 | $-1.39 |
| Year Ago EPS | $-0.41 | $-0.27 | $-0.53 | $-1.34 |
| Year Over Year Growth Estimate | -19.83% | -7.92% | 152.20% | -2.24% |
Insider Information Summary
as of 12/31/1969| % Insiders - 27.31% | |
| % Remaining Total Shares - 72.69% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 0.00 | 0.00 |
| Shares Bought | 0.00 | 0.00 |
| Shares Sold | 0.00 | 0.00 |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
LATEST NEWS
Nano-X Drops After FDA Seeks More Data on New X-Ray System
Aug 19, 2021 3:37 PM EDT
Latest News
Medicinova Jumps on Phase 2 Progress With Alcohol-Abuse Drug
Jun 21, 2021 9:39 AM EDT
Applied Therapeutics Gets Fast Track Designation from FDA
Jun 17, 2021 3:32 PM EDT
Nanox Higher on Application to FDA for Medical Imaging System
Jun 17, 2021 11:13 AM EDT
5 Top Stock Gainers for Monday: Tesla, Invitae, Chembio
Apr 5, 2021 4:35 PM EDT
Bull Market, 2021-Style: Cramer's 'Mad Money' Recap (Tuesday 1/12/21)
Jan 12, 2021 6:54 PM EST
Magnificent Seven: Cramer's 'Mad Money' Recap (Monday 10/19/20)
Oct 19, 2020 7:16 PM EDT
American Renal Associates, Twilio: 5 Top Stock Gainers for Friday
Oct 2, 2020 4:39 PM EDT
Recent Articles from TheStreet
Disney World: Ticket-Price Rises, New Fees, Pricier Food (but Also New Attractions)
People buying Walt Disney World tickets may pay more, but they'll also get more.
Elon Musk Mocks Twitter's Embrace of NFTs
Twitter is offering special profile pictures for NFT holders, meanwhile Musk wants the company to focus on crypto scammers
SPACs Reportedly Lose 2020 Luster; Many Stock Prices Off Sharply
Shares of half the companies that finished SPAC deals in the past two years are down 40% or more, The Wall Street Journal reports.
Crypto Market Lost $1.2 Trillion in 74 Days - and It Might Not Be Over Yet
The ongoing crash in the crypto market has shed roughly $1.2 trillion in value since November 8, and could decline further as "crypto winter" takes hold.
Stock Market Today - 1/21: Netflix Leads Extended Tech Slump, Market Volatility Leaps
Netflix will pace an extended tech stock slump Friday as the Nasdaq navigates its worst start to the year since 2008.
Bitcoin Is Getting Crushed. What Is Bitcoin Really Worth?
Bitcoin has now lost more than 40% of its value since touching nearly $70,000 in November. But what is a bitcoin actually worth, and why?
Netflix Stock Faces $50 Billion Wipeout On Weak Subscriber Growth Outlook As Competition Bites
Netflix shares could erase more than $50 billion in value Friday following a weaker-than-expected forecast for quarterly subscriber growth.
Peloton Stock Rebounds As CEO Hits Back At 'False' Production Halt Report, Plans Costs Cuts
Peloton said reports of a production halt were 'false', but nonetheless vowed "significant corrective actions to improve our profitability outlook and optimize our costs across the company."
Intel Invests $20 Billion To Build Two Chipmaking Plants In Ohio
“Intel’s new facilities will be transformative for our state, creating thousands of good-paying jobs in Ohio manufacturing strategically vital semiconductors," said Governor Mike DeWine.